(UNVB) Unilever - Ratings and Ratios
Beauty Products, Personal Care, Home Care, Food, Ice Cream
UNVB EPS (Earnings per Share)
UNVB Revenue
Description: UNVB Unilever
Unilever Plc is a multinational fast-moving consumer goods company operating across various regions, including Asia Pacific, Africa, the Americas, and Europe, with a diverse portfolio of brands across five business segments: Beauty & Wellbeing, Personal Care, Home Care, Foods, and Ice Cream. The companys product range includes hair care, skin care, oral care, home cleaning products, food condiments, and ice cream, marketed under well-known brand names such as Dove, Axe, Ben & Jerrys, and Hellmanns.
From a strategic perspective, Unilevers diversified product portfolio and global presence provide a solid foundation for revenue growth. Key Performance Indicators (KPIs) to monitor include revenue growth rate, operating margin, and return on equity (RoE). With a reported RoE of 53.67%, Unilever demonstrates a strong ability to generate profits from shareholders equity. Other relevant KPIs include the companys dividend yield, payout ratio, and gross margin. Unilevers brand portfolio is also a critical factor, with a strong presence in the personal care and home care segments.
To further analyze Unilevers performance, its essential to examine its segment-wise revenue contribution, geographic revenue distribution, and product innovation pipeline. The companys ability to adapt to changing consumer preferences, such as the shift towards sustainable and eco-friendly products, will be crucial in driving future growth. Additionally, monitoring Unilevers competitive positioning against peers, such as Procter & Gamble and Nestle, will provide insights into its market share and pricing power.
Unilevers financial health can be assessed by analyzing its debt-to-equity ratio, interest coverage ratio, and cash flow generation. The companys market capitalization of 129.5 billion EUR and a forward P/E ratio of 16.31 indicate a relatively stable and attractive valuation. By tracking these KPIs and fundamental metrics, investors can gain a deeper understanding of Unilevers financial performance and growth prospects.
UNVB Stock Overview
| Market Cap in USD | 152,619m |
| Sub-Industry | Personal Care Products |
| IPO / Inception |
UNVB Stock Ratings
| Growth Rating | 5.33% |
| Fundamental | 80.0% |
| Dividend Rating | 50.6% |
| Return 12m vs S&P 500 | -18.7% |
| Analyst Rating | - |
UNVB Dividends
| Dividend Yield 12m | 3.82% |
| Yield on Cost 5y | 4.88% |
| Annual Growth 5y | 0.21% |
| Payout Consistency | 97.8% |
| Payout Ratio | 73.1% |
UNVB Growth Ratios
| Growth Correlation 3m | -27% |
| Growth Correlation 12m | -58.7% |
| Growth Correlation 5y | 72.5% |
| CAGR 5y | 4.86% |
| CAGR/Max DD 5y | 0.22 |
| Sharpe Ratio 12m | -0.23 |
| Alpha | -8.67 |
| Beta | -0.053 |
| Volatility | 15.81% |
| Current Volume | 3.3k |
| Average Volume 20d | 9k |
| Stop Loss | 51.8 (-3.1%) |
| Signal | -1.25 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (10.56b TTM) > 0 and > 6% of Revenue (6% = 6.35b TTM) |
| FCFTA 0.18 (>2.0%) and ΔFCFTA 4.43pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -5.70% (prev -6.18%; Δ 0.48pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.22 (>3.0%) and CFO 17.40b > Net Income 10.56b (YES >=105%, WARN >=100%) |
| Net Debt (24.52b) to EBITDA (20.12b) ratio: 1.22 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.50b) change vs 12m ago -1.10% (target <= -2.0% for YES) |
| Gross Margin 9.22% (prev 16.17%; Δ -6.95pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 136.6% (prev 120.5%; Δ 16.15pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.75 (EBITDA TTM 20.12b / Interest Expense TTM 2.02b) >= 6 (WARN >= 3) |
Altman Z'' 3.99
| (A) -0.08 = (Total Current Assets 19.19b - Total Current Liabilities 25.23b) / Total Assets 79.75b |
| (B) 0.62 = Retained Earnings (Balance) 49.72b / Total Assets 79.75b |
| (C) 0.23 = EBIT TTM 17.72b / Avg Total Assets 77.51b |
| (D) 0.87 = Book Value of Equity 49.81b / Total Liabilities 57.20b |
| Total Rating: 3.99 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 80.00
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 9.42% = 4.71 |
| 3. FCF Margin 13.60% = 3.40 |
| 4. Debt/Equity 1.48 = 1.50 |
| 5. Debt/Ebitda 1.47 = 1.02 |
| 6. ROIC - WACC 28.28% = 12.50 |
| 7. RoE 53.67% = 2.50 |
| 8. Rev. Trend 18.84% = 0.94 |
| 9. Rev. CAGR 4.45% = 0.56 |
| 10. EPS Trend -31.65% = -0.79 |
| 11. EPS CAGR 21.65% = 2.16 |
What is the price of UNVB shares?
Over the past week, the price has changed by -1.73%, over one month by +5.11%, over three months by -3.65% and over the past year by -4.36%.
Is Unilever a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UNVB is around 45.35 EUR . This means that UNVB is currently overvalued and has a potential downside of -15.14%.
Is UNVB a buy, sell or hold?
What are the forecasts/targets for the UNVB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 49 | -8.4% |
UNVB Fundamental Data Overview
Market Cap EUR = 131.03b (131.03b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 7.63b EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 23.8571
P/E Forward = 17.1233
P/S = 2.1921
P/B = 7.3686
P/EG = 1.8806
Beta = 0.205
Revenue TTM = 105.90b EUR
EBIT TTM = 17.72b EUR
EBITDA TTM = 20.12b EUR
Long Term Debt = 23.29b EUR (from longTermDebt, last quarter)
Short Term Debt = 6.20b EUR (from shortTermDebt, last quarter)
Debt = 29.49b EUR (Calculated: Short Term 6.20b + Long Term 23.29b)
Net Debt = 24.52b EUR (from netDebt column, last quarter)
Enterprise Value = 152.89b EUR (131.03b + Debt 29.49b - CCE 7.63b)
Interest Coverage Ratio = 8.75 (Ebit TTM 17.72b / Interest Expense TTM 2.02b)
FCF Yield = 9.42% (FCF TTM 14.40b / Enterprise Value 152.89b)
FCF Margin = 13.60% (FCF TTM 14.40b / Revenue TTM 105.90b)
Net Margin = 9.97% (Net Income TTM 10.56b / Revenue TTM 105.90b)
Gross Margin = 9.22% ((Revenue TTM 105.90b - Cost of Revenue TTM 96.13b) / Revenue TTM)
Tobins Q-Ratio = 3.07 (Enterprise Value 152.89b / Book Value Of Equity 49.81b)
Interest Expense / Debt = 1.73% (Interest Expense 509.8m / Debt 29.49b)
Taxrate = 28.19% (from yearly Income Tax Expense: 2.50b / 8.87b)
NOPAT = 12.72b (EBIT 17.72b * (1 - 28.19%))
Current Ratio = 0.76 (Total Current Assets 19.19b / Total Current Liabilities 25.23b)
Debt / Equity = 1.48 (Debt 29.49b / last Quarter total Stockholder Equity 19.99b)
Debt / EBITDA = 1.47 (Net Debt 24.52b / EBITDA 20.12b)
Debt / FCF = 2.05 (Debt 29.49b / FCF TTM 14.40b)
Total Stockholder Equity = 19.68b (last 4 quarters mean)
RoA = 13.24% (Net Income 10.56b, Total Assets 79.75b )
RoE = 53.67% (Net Income TTM 10.56b / Total Stockholder Equity 19.68b)
RoCE = 41.24% (Ebit 17.72b / (Equity 19.68b + L.T.Debt 23.29b))
RoIC = 33.26% (NOPAT 12.72b / Invested Capital 38.26b)
WACC = 4.98% (E(131.03b)/V(160.52b) * Re(5.82%)) + (D(29.49b)/V(160.52b) * Rd(1.73%) * (1-Tc(0.28)))
Shares Correlation 5-Years: -100.0 | Cagr: -1.24%
Discount Rate = 5.82% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 77.58% ; FCFE base≈12.74b ; Y1≈12.15b ; Y5≈11.73b
Fair Price DCF = 85.42 (DCF Value 209.43b / Shares Outstanding 2.45b; 5y FCF grow -6.06% → 3.0% )
Revenue Correlation: 18.84 | Revenue CAGR: 4.45%
Rev Growth-of-Growth: 18.49
EPS Correlation: -31.65 | EPS CAGR: 21.65%
EPS Growth-of-Growth: -34.18